10
Views
17
CrossRef citations to date
0
Altmetric
Article

Rift Valley Fever Virus Vaccine Trial: Study of Side-Effects in Humans

Pages 105-109 | Published online: 02 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tetsuro Ikegami. (2019) Candidate vaccines for human Rift Valley fever. Expert Opinion on Biological Therapy 19:12, pages 1333-1342.
Read now

Articles from other publishers (16)

Tong Chen, Zhe Ding, Jiaming Lan & Gary Wong. (2023) Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Jessica R. Harmon, Dominique J. Barbeau, Stuart T. Nichol, Christina F. Spiropoulou & Anita K. McElroy. (2020) Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses. npj Vaccines 5:1.
Crossref
Cynthia M. McMillen & Amy L. Hartman. (2018) Rift Valley fever in animals and humans: Current perspectives. Antiviral Research 156, pages 29-37.
Crossref
Kaori Terasaki, Breanna R. Tercero & Shinji Makino. (2016) Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates. Virus Research 216, pages 55-65.
Crossref
Inaia Phoenix & Tetsuro Ikegami. 2015. Human Emerging and Re‐emerging Infections. Human Emerging and Re‐emerging Infections 73 94 .
Stefan W. Metz & Gorben P. Pijlman. (2011) Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system. Journal of Invertebrate Pathology 107, pages S16-S30.
Crossref
Janice M. Rusnak, Paul Gibbs, Ellen Boudreau, Denise P. Clizbe & Phillip Pittman. (2011) Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study. Vaccine 29:17, pages 3222-3229.
Crossref
Tetsuro Ikegami & Shinji Makino. (2009) Rift Valley fever vaccines. Vaccine 27, pages D69-D72.
Crossref
Stanley J. CryzJr.Jr., Marta Granstrom, Bruno Gottstein, Luc Perrin, Alan Cross & James Larrick. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Phillip R. Pittman, C.T. Liu, Timothy L. Cannon, Richard S. Makuch, Joseph A. Mangiafico, Paul H. Gibbs & Clarence J. Peters. (1999) Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine 18:1-2, pages 181-189.
Crossref
Gilcin F. MeadorsIIIIII, Paul H. Gibbs & C.J. Peters. (1986) Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials. Vaccine 4:3, pages 179-184.
Crossref
B. Niklasson, C.J. Peters, E. Bengtsson & E. Norrby. (1985) Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans. Vaccine 3:2, pages 123-127.
Crossref
J.D. Kark, Y. Aynor & C.J. Peters. (1985) A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection. Vaccine 3:2, pages 117-122.
Crossref
C.R. Howard. (1984) Viral haemorrhagic fevers: properties and prospects for treatment and prevention. Antiviral Research 4:4, pages 169-185.
Crossref
B. Hofman & H.P. Lansberg. 1984. 298 302 .
Robert SteffenRobert Steffen. 1984. Reisemedizin. Reisemedizin 181 212 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.